AIM: ABATACEPT IN INADEQUATE RESPONDERS TO METHOTREXATE

DEAD

Serial Number

78416531

Owner

BRISTOL-MYERS SQUIBB COMPANY

Attorney

Marilyn F. Kelly

First Use Date

Jun 20, 2006

Filing Date

May 11, 2004

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

AIM: ABATACEPT IN INADEQUATE RESPONDERS TO METHOTREXATE Trademark

Serial Number: 78416531 • Registration: 3565840

AIM: ABATACEPT IN INADEQUATE RESPONDERS TO METHOTREXATE is a trademark filed by BRISTOL-MYERS SQUIBB COMPANY on May 11, 2004. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

BRISTOL-MYERS SQUIBB COMPANY (4,814 trademarks)

NEW YORK, NY 10154

Entity Type: 03

Legal Representation

Attorney of Record

Marilyn F. Kelly

2,565 trademarks filed View all →

Trademark Details

Filing Date

May 11, 2004

Registration Date

January 20, 2009

First Use Anywhere

June 20, 2006

First Use in Commerce

June 20, 2006

Published for Opposition

September 13, 2005

Cancellation Date

August 21, 2015

Goods & Services

Clinical trials relating to pharmaceutical preparations for human use

Filing History

CANCELLED SEC. 8 (6-YR)

Aug 21, 2015 C8..

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Apr 19, 2011 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Apr 19, 2011 REAP

REGISTERED-PRINCIPAL REGISTER

Jan 20, 2009 R.PR

LAW OFFICE REGISTRATION REVIEW COMPLETED

Dec 17, 2008 REGV

ASSIGNED TO LIE

Dec 17, 2008 ALIE

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Dec 10, 2008 CNPR

EXAMINERS AMENDMENT MAILED

Dec 10, 2008 CNEA

EXAMINER'S AMENDMENT ENTERED

Dec 9, 2008 XAEC

SU-EXAMINER'S AMENDMENT WRITTEN

Dec 9, 2008 SNEA

STATEMENT OF USE PROCESSING COMPLETE

Dec 9, 2008 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 9, 2008 AITU

USE AMENDMENT FILED

Dec 1, 2008 IUAF

TEAS STATEMENT OF USE RECEIVED

Dec 1, 2008 EISU

REVIEW OF CORRESPONDENCE COMPLETE

Jul 11, 2008 CORV

ASSIGNED TO EXAMINER

Jun 12, 2008 DOCK

SOU TEAS EXTENSION RECEIVED

Apr 30, 2008 EEXT

SOU EXTENSION 5 GRANTED

Apr 30, 2008 EX5G

SOU EXTENSION 5 FILED

Apr 30, 2008 EXT5

SOU TEAS EXTENSION RECEIVED

Apr 30, 2008 EEXT

SOU EXTENSION 4 GRANTED

Nov 9, 2007 EX4G

SOU EXTENSION 4 FILED

Nov 9, 2007 EXT4

SOU TEAS EXTENSION RECEIVED

Nov 9, 2007 EEXT

SOU EXTENSION 3 GRANTED

May 14, 2007 EX3G

SOU EXTENSION 3 FILED

May 14, 2007 EXT3

SOU TEAS EXTENSION RECEIVED

May 14, 2007 EEXT

SOU EXTENSION 2 GRANTED

Oct 2, 2006 EX2G

SOU EXTENSION 2 FILED

Oct 2, 2006 EXT2

SOU TEAS EXTENSION RECEIVED

Oct 2, 2006 EEXT

SOU EXTENSION 1 GRANTED

Apr 3, 2006 EX1G

SOU EXTENSION 1 FILED

Apr 3, 2006 EXT1

SOU TEAS EXTENSION RECEIVED

Apr 3, 2006 EEXT

NOA MAILED - SOU REQUIRED FROM APPLICANT

Dec 6, 2005 NOAM

PUBLISHED FOR OPPOSITION

Sep 13, 2005 PUBO

NOTICE OF PUBLICATION

Aug 24, 2005 NPUB

LAW OFFICE PUBLICATION REVIEW COMPLETED

May 20, 2005 PREV

ASSIGNED TO LIE

May 20, 2005 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

May 11, 2005 CNSA

AMENDMENT FROM APPLICANT ENTERED

May 11, 2005 ACEC

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 10, 2005 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 10, 2005 TROA

NON-FINAL ACTION MAILED

Dec 29, 2004 CNRT

NON-FINAL ACTION WRITTEN

Dec 28, 2004 CNRT

ASSIGNED TO EXAMINER

Dec 9, 2004 DOCK

NEW APPLICATION ENTERED

May 18, 2004 NWAP

Related Trademarks

More from this Owner

EMPLICITI

ZYWISPO

AMWISPO

More in Same Class

DIGITAL ANSWER MAN

YOURDOVE

ATTAIN - ABATACEPT TRIAL IN TREATMENT OF ANTI-TNF INADEQUATE RESPONDERS

ASSURE - ABATACEPT STUDY OF SAFETY IN USE WITH OTHER RA THERAPIES

BOMBAY CHOPSTICKS

DIGITAL ANSWER MAN